Previous 10 | Next 10 |
2024-05-22 09:45:00 ET The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer . Smaller biotechs that tried to dominate this market were much less successful. That group includes Novavax (NASDAQ: NVAX) and Inovi...
Now available for sale through N. American mobile network operators and resellers Inseego Corp. (Nasdaq: INSG), a leader in 5G edge cloud solutions, announced the industry’s first FIPS 140-2 (Federal Information Processing Standard Publication 140-2) certified 5G mobile hotspot. ...
2024-05-20 16:31:03 ET Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference Call May 20, 2024, 12:30 PM ET Company Participants Jacqueline Shea - President & Chief Executive Officer Michael Sumner - Chief Medical Officer ...
2024-05-15 14:15:34 ET Inovio Pharmaceuticals, Inc. (INO) RBC Capital Markets Global Healthcare Conference May 15, 2024 10:00 AM ET Company Participants Jacqueline Shea - CEO Mike Sumner - Chief Medical Officer Conference Call Participants Gregory Renza -...
2024-05-14 16:44:07 ET Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference May 14, 2024, 11:30 AM ET Company Participants Jacqueline Shea - CEO Conference Call Participants Roy Buchanan - Citizens JMP Presentation Roy Bu...
2024-05-13 21:45:14 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2024 Earnings Call May 13, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call ...
2024-05-13 19:47:09 ET Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Conference Call May 13, 2024, 04:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President and Chief Executive Officer Michael Sumner - Chief Me...
2024-05-13 18:00:04 ET Sudan Loganathan from Stephens issued a price target of $20.00 for INO on 2024-05-13 16:32:00. The adjusted price target was set to $20.00. At the time of the announcement, INO was trading at $11.36. The overall price target consensus is at $4.00 w...
2024-05-13 16:07:13 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation Inovio Pharmaceuticals: The Dilution Continues Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript Inovi...
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights PR Newswire BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgical treatment for recurrent respiratory papilloma...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...